Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report

被引：67
|
作者：
Schifitto, G
Peterson, DR
Zhong, J
Ni, H
Cruttenden, K
Gaugh, M
Gendelman, HE
Boska, M
Gelbard, H
机构：
[1] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biostat, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Radiol, Rochester, NY 14642 USA
[4] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA
[5] Univ Nebraska, Med Ctr, Dept Radiol, Omaha, NE 68105 USA
来源：
NEUROLOGY | 2006年 / 66卷 / 06期
关键词：
D O I：
10.1212/01.wnl.0000204294.28189.03
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In vitro and animal model data demonstrate that valproic acid (VPA) can ameliorate HIV-associated neurotoxicity. The authors conducted a pilot 10-week placebo-controlled study of VPA 250 mg twice daily in 22 HIV-infected individuals with (n = 16) and without (n = 6) cognitive impairment. VPA was safe and well tolerated, with trends toward improved neuropsychological performance and brain metabolism in the impaired subjects.
引用
收藏
页码：919 / 921
页数：3
相关论文
共 50 条
  • [1] Parkinsonism and cognitive impairment associated with chronic valproic acid therapy
    Masmoudi, K
    Gras-Champel, V
    Bonnet, I
    Pannier, M
    Masson, H
    Rosa, A
    Andréjak, M
    THERAPIE, 2000, 55 (05): : 629 - 634
  • [2] HIV-associated cognitive impairment before and after the advent of combination therapy
    Ned Sacktor
    Michael P. McDermott
    Karen Marder
    Giovanni Schifitto
    Ola A. Selnes
    Justin C. McArthur
    Yaakov Stern
    Steve Albert
    Donna Palumbo
    Karl Kieburtz
    Joy A. De Marcaida
    Bruce Cohen
    Leon Epstein
    Journal of NeuroVirology, 2002, 8 : 136 - 142
  • [3] HIV-associated cognitive impairment before and after the advent of combination therapy
    Sacktor, N
    McDermott, MP
    Marder, K
    Schifitto, G
    Selnes, OA
    McArthur, JC
    Stern, Y
    Albert, S
    Palumbo, D
    Kieburtz, K
    De Marcaida, JA
    Cohen, B
    Epstein, L
    JOURNAL OF NEUROVIROLOGY, 2002, 8 (02) : 136 - 142
  • [4] Parkinsonism and/or cognitive impairment with valproic acid therapy:: A report of ten cases
    Masmoudi, K
    Gras-Champel, V
    Masson, H
    Andréjak, M
    PHARMACOPSYCHIATRY, 2006, 39 (01) : 9 - 12
  • [5] Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of 21 cases
    Azzoug, M.
    Routier, S.
    Gras, V.
    Masson, H.
    Andrejak, M.
    Masmoudi, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 56 - 56
  • [6] Sex differences in HIV-associated cognitive impairment
    Sundermann, Erin E.
    Heaton, Robert K.
    Pasipanodya, Elizabeth
    Moore, Raeanne C.
    Paolillo, Emily W.
    Rubin, Leah H.
    Ellis, Ronald
    Moore, David J.
    AIDS, 2018, 32 (18) : 2719 - 2726
  • [7] Cognitive impairment in patients with HIV-associated myelopathy
    Scarano, A
    Dorfman, D
    Gongvatana, A
    Di Rocco, A
    NEUROLOGY, 2001, 56 (08) : A475 - A475
  • [8] Neuroinflammation and HIV-Associated Cognitive Impairment Can They Be Eradicated?
    Wojna, Valerie
    NEUROLOGY, 2022, 99 (12) : 499 - 500
  • [9] Clinical and spectroscopic improvement in HIV-associated cognitive impairment
    Stankoff, B
    Tourbah, A
    Suarez, S
    Turell, E
    Stievenart, JL
    Payan, C
    Coutellier, A
    Herson, S
    Baril, L
    Bricaire, F
    Calvez, V
    Cabanis, EA
    Lacomblez, L
    Lubetzki, C
    NEUROLOGY, 2001, 56 (01) : 112 - 115
  • [10] Minocycline Treatment for HIV-Associated Cognitive Impairment in Uganda
    Sacktor, Ned
    Nakasujja, Noeline
    Miyahara, Sachiko
    Lee, Anthony
    Evans, Scott
    Robertson, Kevin
    Katabira, Elly
    Musisi, Seggane
    Clifford, David
    NEUROLOGY, 2011, 76 (09) : A23 - A23
12345